Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmacological Research

• Publication date

  2016-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.phrs.2016.07.041PMID 27475881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer-Related Inflammation in Tumor Progression

  2018cited by this paper
• Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.

  2016cited by this paper
• Gasotransmitters in cancer: from pathophysiology to experimental therapy

  2015cited by this paper
• Endogenous Prostaglandins and Afferent Sensory Nerves in Gastroprotective Effect of Hydrogen Sulfide against Stress-Induced Gastric Lesions

  2015cited by this paper
• Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter

  2015cited by this paper
• Anti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics

  2015cited by this paper
• A Fast Hydrogen Sulfide–Releasing Donor Increases the Tumor Response to Radiotherapy

  2015cited by this paper
• Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression

  2015cited by this paper
• Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity

  2015cited by this paper
• Hydrogen Sulfide Protects from Colitis and Restores Intestinal Microbiota Biofilm and Mucus Production

  2015cited by this paper
• The Therapeutic Potential of Cystathionine β-Synthetase/Hydrogen Sulfide Inhibition in Cancer

  2015cited by this paper
• Hydrogen sulphide protects against NSAID‐enteropathy through modulation of bile and the microbiota

  2015cited by this paper
• A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus

  2015cited by this paper
• H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential.

  2015cited by this paper
• Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.

  2015cited by this paper
• Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling

  2015cited by this paper
• Anti-Cancer Activity of New Designer Hydrogen Sulfide-Donating Hybrids

  2014cited by this paper
• Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis

  2014cited by this paper
• Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.

  2014cited by this paper
• Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation

  2013cited by this paper
• The Proapoptotic Effect of Traditional and Novel Nonsteroidal Anti-Inflammatory Drugs in Mammalian and Yeast Cells

  2013cited by this paper
• Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro.

  2013cited by this paper
• Chemoprevention of cancers in gastrointestinal tract with cyclooxygenase 2 inhibitors.

  2013cited by this paper
• Polypharmacy of Osteoarthritis: The Perfect Intestinal Storm

  2013cited by this paper
• Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer

  2013cited by this paper
• Hydrogen Sulfide Protects Against Cellular Senescence via S-Sulfhydration of Keap1 and Activation of Nrf2

  2013cited by this paper
• Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

  2013cited by this paper
• Enhanced Synthesis and Diminished Degradation of Hydrogen Sulfide in Experimental Colitis: A Site-Specific, Pro-Resolution Mechanism

  2013cited by this paper
• Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.

  2012cited by this paper
• Improved survival with MEK inhibition in BRAF-mutated melanoma.

  2012cited by this paper
• A landscape of driver mutations in melanoma.

  2012cited by this paper
• Hydrogen Sulfide: An Endogenous Mediator of Resolution of Inflammation and Injury

  2012cited by this paper
• Gastroprotective Effect of NaHS Against Mucosal Lesions Induced by Ischemia–Reperfusion Injury in Rat

  2012cited by this paper
• Modifying effect of diallyl sulfide on colon carcinogenesis in C57BL/6J-ApcMin/⁺ mice.

  2012cited by this paper
• Hydrogen Sulfide Is a Signaling Molecule and a Cytoprotectant

  2012cited by this paper
• Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.

  2012cited by this paper
• Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence

  2012cited by this paper
• The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo

  2011cited by this paper
• Raf kinases in cancer–roles and therapeutic opportunities

  2011cited by this paper
• Detection of hydrogen sulfide in plasma and knee‐joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation

  2010cited by this paper
• Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species

  2010cited by this paper
• Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

  2010cited by this paper
• R-flurbiprofen suppresses distal nonmucin-producing colorectal tumors in azoxymethane-treated rats, without suppressing eicosanoid production.

  2010cited by this paper
• Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals.

  2010cited by this paper
• Markedly reduced toxicity of a hydrogen sulphide‐releasing derivative of naproxen (ATB‐346)

  2010cited by this paper
• Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats.

  2009cited by this paper
• Hydrogen sulfide is an endogenous stimulator of angiogenesis

  2009cited by this paper
• Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.

  2008cited by this paper
• Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?

  2008cited by this paper
• Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer.

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Celecoxib for the Prevention of Colorectal Adenomatous Polyps

  2008cited by this paper
• Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.

  2007cited by this paper
• Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative.

  2007cited by this paper
• Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitis

  2007cited by this paper
• Hydrogen sulfide enhances ulcer healing in rats

  2007cited by this paper
• Identification of gene signatures for invasive colorectal tumor cells.

  2007cited by this paper
• Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways

  2006cited by this paper
• Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation

  2006cited by this paper
• Development of a New Melanoma Model in C 57 BL / 6 Mice 1

  2006cited by this paper
• Evidence That Hydrogen Sulfide Exerts Antinociceptive Effects in the Gastrointestinal Tract by Activating KATP Channels

  2006cited by this paper
• Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

  2006cited by this paper
• Celecoxib for the prevention of sporadic colorectal adenomas.

  2006cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Celecoxib for the prevention of colorectal adenomatous polyps.

  2006cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.

  2005cited by this paper
• Emerging roles for cyclooxygenase‐2 in gastrointestinal mucosal defense

  2005cited by this paper
• Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)*

  2004cited by this paper
• Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention.

  2002cited by this paper
• Role of CXCL1 in tumorigenesis of melanoma

  2002cited by this paper
• Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels

  2001cited by this paper
• Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family

  2000cited by this paper
• pap, reg Ialpha and reg Ibeta mRNAs are concomitantly up-regulated during human colorectal carcinogenesis.

  1999cited by this paper
• Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study.

  1999cited by this paper
• pap, reg Iα and reg Iβ mRNAs are concomitantly up‐regulated during human colorectal carcinogenesis

  1999cited by this paper
• Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.

  1998cited by this paper
• Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIIIα, RegIIIβ, RegIIIγ

  1997cited by this paper
• Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIII alpha, RegIII beta, RegIII gamma.

  1997cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings.

  1987cited by this paper
• Development of a new melanoma model in C57BL/6 mice.

  1982cited by this paper
• Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane.

  1973cited by this paper

• Hydrogen sulfide rescues IFNγ/TNFα-induced intestinal epithelial barrier dysfunction by enhancing oxidative phosphorylation.

  2026cites this paper
• The Mediating Role of the Gut Microbiome in the Nutritional Prevention of Cancer.

  2025cites this paper
• Glutathione-responsive nanoplatforms trigger gaseous intervention of intestinal inflammation through TLR4/MD2/MyD88/NF-κB/iNOS pathway activation and gut microbiota modulation

  2024cites this paper
• Recent advances in the role of endogenous hydrogen sulphide in cancer cells

  2023cites this paper
• A mitochondria-targeting “off–on” AIE probe with large Stokes shift for high-contrast H2S imaging in living cells

  2023cites this paper
• Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

  2022cites this paper
• Evodiamine-A Privileged Structure with Broad-Ranging Biological Activities.

  2022cites this paper
• ANKRD22 is a novel therapeutic target for gastric mucosal injury.

  2022cites this paper
• Differential effects of subchronic acrylonitrile exposure on hydrogen sulfide levels in rat blood, brain, and liver.

  2022cites this paper
• Physiological roles of hydrogen sulfide in mammalian cells, tissues and organs.

  2022cites this paper
• NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future.

  2021cites this paper
• Postbiotics, Metabolic Signaling, and Cancer

  2021cites this paper
• Role of the oral microbiota in cancer evolution and progression

  2020cites this paper
• Hydrogen Sulfide Metabolism and Signaling in the Tumor Microenvironment.

  2020cites this paper
• New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer

  2020cites this paper
• Anticancer Activities of Erucin a H2S-Donor Isothiocyanate From Eruca Sativa Mill.: Is H2S the Real Player?

  2019cites this paper
• Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways.

  2019cites this paper
• Protein S‐sulfhydration by hydrogen sulfide in cardiovascular system

  2018cites this paper
• HYDROGEN SULFIDE SYSTEM ATTENUATES INJURY BY HYPERGLYCEMIA AND STRESS: THE ROLE OF MESENTERIC ADIPOCYTES IN AGED ANIMALS

  2018cites this paper
• Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties.

  2018cites this paper
• Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of Helicobacter hepaticus-Induced Colitis

  2018cites this paper
• Anti-inflammatory effects of H2S during acute bacterial infection: a review

  2017cites this paper
• Esterase Activated Carbonyl Sulfide/Hydrogen Sulfide (H2S) Donors.

  2017cites this paper
• Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs

  2017cites this paper
• A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator.

  2017cites this paper
• Novel silver complexes with popular non-steroidal anti-inflammatory drugs

  2016cites this paper
• Diet, microorganisms and their metabolites, and colon cancer

  2016cites this paper